PAAB is developing an industry wide group to explore and address opportunities, barriers, and challenges associated with the implementation of AI in pharma marketing and market access.

Participants will have the opportunity to voice their concerns, share insights, and contribute to shaping best practices for AI integration as well as those of their respective organizations. Input will be invaluable in navigating potential concerns and landmines, ultimately leading to a more informed and strategic approach to AI for the industry.

We are looking to foster open and comprehensive discussion on a wide range of topics which could include, the extent of disclosure of AI usage in industry operations may require, the potential implications of job roles and responsibilities, perceived internal and external regulatory hurdles, cost, or quality control. These are just a few issues we’ve heard so far, and we anticipate the group will generate more.

The conclusion of this project might be publication of a summary of the discussions. Or, it may lead to greater things like industry best practices, ways to navigate concerns/landmines, ways to remove/overcome barriers etc.

We are looking for individuals who are well versed in artificial intelligence and large language models and are leading or deeply involved in the development or implementation of AI driven projects.

If you’re interested, please send a summary of your role and experience with AI to info@paab.ca.